what is the dosing schedule for retatrutide A Clinician's Guide to Retatrutide dosage chart for weight

Overall the results of this study, which followed over 200,000 people with diabetes who were treated with GLP1RAs and compared them to over 1.5 million people on other forms of diabetes treatment, is reassuring regarding the risk/benefit ratio for the long term use of GLP1RAs in people with diabetes

Are labs and symptoms being monitored

Semaglutide's data are built on over 25,000 participants across more than 20 randomized controlled trials, including the largest cardiovascular outcomes trial ever conducted for an anti-obesity medication

Tirzepatide (Mounjaro for diabetes, Zepbound for weight loss) are also sometimes included with GLP1s, although they work a little differently

Consistent weekly injections are crucial for semaglutide to be effective

The result is one final dose